Efungumab
- Generic Name
- Efungumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 762260-74-2
- Unique Ingredient Identifier
- BM86P708HW
- Background
Efungumab is under investigation in clinical trial NCT00217815 (Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer).
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS
- First Posted Date
- 2006-05-10
- Last Posted Date
- 2008-12-12
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 3
- Registration Number
- NCT00324025
- Locations
- 🇺🇸
University of Alabama School of Medicine, Birmingham, Alabama, United States
🇺🇸Department of Medicine/Infectious Disease, MC 7881, University of Texas Health Science Center, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath